About: Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
Creator	Earley, Bernadette Morrison, Steven Duffy, Catherine Dunn, Amanda Tiernan, Katie Waters, Sinead Mcgee, Mark
Source	Elsevier; Medline; PMC
abstract	Abstract The study objectives were: 1) to characterise the development of immunocompetence in beef suckler calves from birth to three months of age, and 2) to trace glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) antibodies from dam to calf and subsequent vaccination against pneumonia. Thirty multiparous beef suckler, spring-calving cows, consisting of two genotypes were involved; Limousin×Friesian (LF) and Charolais×Limousin (CL). Cows were immunised against the inactivated antigen strain of BoHV-1 (gE- (IBR marker vaccine) at day −84 and received a booster at day −56 relative to the expected calving date (d 0). Calves were immunised at 14 and 42days of age against PI-3 virus, BRSV and Mannheimia (Pasteurella) haemolytica serotype A1 using a commercial vaccine administered subcutaneously. Additionally, calves were immunised against BoHV-1 at 42days of age, using 1 dose of a live commercial vaccine administered intranasally. Blood samples were collected from all calves (n=30) via jugular venipuncture at birth, prior to colostrum feeding (0h), at 12h (h), 24h, 72h and 168h after the initial feeding of colostrum, and at d 7, 14, 28, 42, 56 and 84 post birth. The mean ratio of gE negative antibodies circulating in the blood of LF and CL dams pre-partum scored negative to gE ab (S/N≥0.70). Antibody levels of BoHV-1 (wild type (wt)) peaked at 12h post-birth in calves and declined thereafter, as the maternal antibodies decayed. There was no difference in BoHV-1 and BRSV antibody levels in calves post vaccination.
has issue date	2018-06-30(xsd:dateTime)
bibo:doi	10.1016/j.rvsc.2018.01.005
bibo:pmid	29421483
has license	els-covid
sha1sum (hex)	9abae6d42408001482d4bc1d9eb2fc2fd9635177
schema:url	https://doi.org/10.1016/j.rvsc.2018.01.005
resource representing a document's title	Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
has PubMed Central identifier	PMC7111865
has PubMed identifier	29421483
schema:publication	Research in Veterinary Science
resource representing a document's body	covid:9abae6d42408001482d4bc1d9eb2fc2fd9635177#body_text
is schema:about of	named entity 'S/N' named entity 'feeding' named entity 'beef' named entity 'calf' named entity 'negative' named entity 'negative' covid:arg/9abae6d42408001482d4bc1d9eb2fc2fd9635177 named entity 'peaked' named entity 'dams' named entity 'venipuncture' named entity 'trace' named entity 'age' named entity 'intranasally' named entity 'calves' named entity 'levels' named entity 'blood' named entity 'feeding' named entity 'wild type' named entity 'beef' named entity 'prepartum' named entity 'multiparous' named entity 'Antibody' named entity 'antibodies' named entity 'maternal antibodies' named entity 'bovine' named entity 'virus' named entity 'immunised' named entity 'vaccination' named entity 'herpesvirus' named entity 'IgG' named entity 'antigen' named entity 'neonatal' named entity 'ad libitum' named entity 'vaccination' named entity 'virus' named entity 'Th2' named entity 'vaccination' named entity 'IBR' named entity 'Cow' named entity 'colostrum' named entity 'Männedorf' named entity 'WBC' named entity 'optical density' named entity 'ZST' named entity 'parturition' named entity 'post-partum' named entity 'centrifugation' named entity 'statistical model' named entity 'haematological' named entity 'viruses' named entity 'colostrum' named entity 'd 3' named entity 'IgG' named entity 'respiratory syncytial virus' named entity 'IgG' named entity 'infection' named entity 'vaccine' named entity 'weaning' named entity 'mixed model' named entity 'post-partum' named entity 'calibration curve' named entity 'Neutrophil' named entity 'Ireland' named entity 'Type III sums of squares' named entity 'IBR' named entity 'antibody' named entity 'infection' named entity 'cattle' named entity 'Teagasc' named entity 'absorbance' named entity 'gene coding' named entity 'Siemens' named entity 'virulence factor' named entity 'vaccine' named entity 'PDIFF'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software